Pekin Hardy Strauss’s GSK GSK Stock Holding History

Pekin Hardy Strauss’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,325	Closed	-$344K	–	323
2022 Q2	$344K	Sell	6,325 -500	-7%	-$27.6K	0.05%	231
2022 Q1	$372K	Buy	6,825 +120	+2%	+$6.52K	0.05%	256
2021 Q4	$370K	Buy	6,705 +116	+2%	+$6.03K	0.05%	249
2021 Q3	$315K	Buy	6,589 +432	+7%	+$21.7K	0.04%	263
2021 Q2	$306K	Buy	6,157 +1,064	+21%	+$51.1K	0.04%	257
2021 Q1	$227K	Buy	+5,093	New	+$231K	0.04%	271
2020 Q3	–	Sell	-3,997	Closed	-$204K	–	244
2020 Q2	$204K	Buy	+3,997	New	+$205K	0.05%	198
2020 Q1	–	Sell	-3,997	Closed	-$235K	–	213
2019 Q4	$235K	Hold	3,997	–	–	0.04%	192
2019 Q3	$213K	Buy	+3,997	New	+$206K	0.04%	183
2019 Q2	–	Sell	-4,089	Closed	-$214K	–	208
2019 Q1	$214K	Buy	+4,089	New	+$204K	0.02%	182
2018 Q4	–	Sell	-4,289	Closed	-$215K	–	201
2018 Q3	$215K	Sell	4,289 -1,196	-22%	-$60.8K	0.04%	181
2018 Q2	$276K	Buy	5,485 +52	+1%	+$2.62K	0.05%	159
2018 Q1	$265K	Hold	5,433	–	–	0.05%	161
2017 Q4	$241K	Buy	5,433 +1,020	+23%	+$47.1K	0.04%	166
2017 Q3	$224K	Hold	4,413	–	–	0.04%	162
2017 Q2	$238K	Hold	4,413	–	–	0.04%	159
2017 Q1	$233K	Buy	4,413 +48	+1%	+$2.44K	0.05%	157
2016 Q4	$210K	Sell	4,365 -32	-0.7%	-$1.58K	0.02%	157
2016 Q3	$237K	Sell	4,397 -800	-15%	-$43.9K	0.04%	140
2016 Q2	$282K	Sell	5,197 -600	-10%	-$31.6K	0.06%	129
2016 Q1	$294K	Buy	+5,797	New	+$289K	0.07%	124

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Pekin Hardy Strauss's GSK Position: Q3 2022 in Review

Pekin Hardy Strauss sold out of GSK (GSK) in Q3 2022, closing a stake of 6,325 shares — an estimated $344K sold.

Pekin Hardy Strauss first reported a position in GSK in Q1 2016 and held it in 21 quarters. The position peaked at $372K in Q1 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Pekin Hardy Strauss reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Pekin Hardy Strauss sold 6,325 GSK shares in Q3 2022, an estimated $344K.
Pekin Hardy Strauss first reported a position in GSK in Q1 2016 and held it in 21 quarters.
Pekin Hardy Strauss's GSK position peaked at $372K in Q1 2022.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Pekin Hardy Strauss's 13F filing for Q3 2022, filed 9 Nov 2022.